Innovation Pharmaceuticals Inc (IPIX)

[frrol]

Share price appreciation doesn't happen in a vacuum. Funding was clearly a concern for that company and its market cap was apparently low in the market's view (ie, share price was very attractive).

I think Cellceutix may be viewed viewed as a bit slow and erratic in its clinical programs. I disagree, but I only get one vote in the market Anyway its market cap is substantial compared to some other young biotechs, commensurate with its progress, though I think it should be higher. But then again, that's why I hold so many shares.